Cegedim Health Data to collaborate with IBM Watson Health to provide integrated access to real world data
June 18 2020 - 11:30AM
Cegedim Health Data to collaborate with IBM Watson Health to
provide integrated access to real world data
June 16, 2020
- Cegedim Health Data
today announced a collaboration with IBM Watson Health to
integrate clinical rich real-world data from The Health Improvement
Network, THIN®, a Cegedim
electronic health record (EHR) database, into IBM Watson Health’s
real-world evidence solution portfolio. The integration of
THIN® will support IBM Watson
Health research services and IBM MarketScan® Treatment Pathways
with offering life sciences and pharmaceutical clients access to
rich and diverse European real-world data (RWD).
The THIN® database, which includes clinical data
beyond biometrics such as diagnoses, treatments, clinical outcomes
and interventions, will complement IBM’s proprietary databases for
use in executing high-quality research studies and a self-service
analytic tool to support life sciences clients.
“Many life sciences
companies are pursuing market access in Europe and require a fully
integrated solution to access real-world data. We can help address
this emerging need by integrating the THIN® database directly into
IBM Watson Health research services and IBM MarketScan Treatment
Pathways. This collaboration further enables IBM Watson Health and
Cegedim Health Data to support clients with a unified approach to
evidence generation, thereby helping to streamline clients'
commercialization and market access strategies,” said Mary Presti,
Vice President of Life Sciences at IBM Watson Health.
This collaboration supports IBM Watson Health in
developing meaningful use cases and insights for their clients
using high-quality European real-world data. Not only does IBM have
access to this European real-world dataset through its research
services and self-service analytic solution, its researchers are
trained to leverage the strengths of THIN®, which includes rich,
longitudinal, anonymised and representative real-world data
with a history dating back to 1994.
The collaboration comes at a time when the value
of real-world data is arguably greater than ever before, as
organisations and institutions globally seek answers to some of the
industry’s biggest challenges. The European Medicines Agency has
recognised that RWD analyses can support important investigations,
and has called for a learning healthcare system at the
international level based on data gathered in everyday practice to
generate new knowledge.
Gilles Paubert, Global
Head, Cegedim Health Data, concludes: “Cegedim is committed to
enabling advancements in patient outcomes. Combining THIN® data and
experts with IBM’s high-quality research experience and analytics
platform presents a very real opportunity to help improve the
potential of real-world data and provide that with every new
patient treated, we know more overall about the practice of
medicine.”
About Cegedim Health Data: Cegedim Health
Data is part of the Cegedim Group, an innovative Technology,
Services and Real World Data Company that has specialised in the
healthcare field for more than 50 years. Cegedim Health Data
provides Real World Data and Evidence (RWD-E) to drive cutting edge
improvements in patient outcomes. With a data history of over 24
years and millions of anonymised patient records immediately
accessible from our THIN® (The Health Improvement Network)
European database.To learn more,
visit www.cegedim-health-data.com
About Cegedim: Founded in 1969, Cegedim is an
innovative technology and services company in the field of digital
data flow management for healthcare ecosystems and B2B, and a
business software publisher for healthcare and insurance
professionals. Cegedim employs almost 5,000 people in more than 10
countries and generated revenue in excess of €500 million in 2019.
Cegedim SA is listed in Paris (EURONEXT: CGM).
To learn more, please visit: www.cegedim.comAnd
follow Cegedim on Twitter: @CegedimGroup, LinkedIn and
Facebook.
Aude
BalleydierCegedimMedia Relations and
Communications ManagerTel.: +33 (0)1 49 09 68
81aude.balleydier@cegedim.com |
Gilles PaubertCegedim Health Data
Global Head of Health DataTel : +33 (0)1 49 09 67 07
gilles.paubert@cegedim.fr |
Josephine TimminsNeo PR, on behalf of
Cegedim UK Account Director Tel : +44 (0) 1296
733867 cegedim@neopr.co.uk |
|
- CegedimHealthData_IBM_Watson_16062020_ENG
Cegedim (EU:CGM)
Historical Stock Chart
From Sep 2024 to Oct 2024
Cegedim (EU:CGM)
Historical Stock Chart
From Oct 2023 to Oct 2024